Skip to main content
Equibles

BAKER BROS. ADVISORS LP

Position in SGMT — Sagimet Biosciences Inc.

CIK 1263508 NEW YORK, NY
Back to SGMT Full portfolio

Position in SGMT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$7,366,659
+$2,387,255 QoQ
Shares Held
952,996
0.0% QoQ
Ownership
1.53%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#15
of 122 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SGMT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BAKER BROS. ADVISORS LP holds $18,875,530,286 across 78 Biotechnology names. SGMT ranks #66 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INCY
Incyte Corp
 30,762,330 $3,487,217,728
2 ONC
BeOne Medicines Ltd.
 8,801,567 $2,508,182,547
3 RVMD
Revolution Medicines, Inc.
 11,443,357 $2,143,111,898
4 MDGL
Madrigal Pharmaceuticals, Inc.
 2,143,131 $1,150,754,190
5 ACAD
Acadia Pharmaceuticals Inc
 42,912,904 $1,085,696,471
6 KYMR
Kymera Therapeutics, Inc.
 8,657,242 $992,725,940
7 INSM
INSMED Inc
 8,796,111 $937,841,354
8 CELC
Celcuity Inc.
 7,915,792 $828,150,159

All Filings in SGMT

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,366,659 952,996
2026-03-31 $4,979,404 952,996
2025-12-31 $5,641,736 952,996
2025-09-30 $6,537,552 952,996
2025-06-30 $7,261,829 952,996
2025-03-31 $3,106,766 952,996
2024-12-31 $4,288,482 952,996
2024-09-30 $3,827,857 1,381,898
2024-06-30 $4,726,091 1,381,898
2024-03-31 $7,489,887 1,381,898
2023-12-31 $7,894,327 1,456,518
2023-09-30 $7,175,159 815,359